Rohto Pharmaceutical (4527)

Tokyo
Currency in JPY
2,452.5
-40.5(-1.62%)
Delayed Data
4527 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
2,443.02,499.0
52 wk Range
2,443.03,688.0
Key Statistics
Edit
Bid/Ask
2,451.50 / 2,453.00
Prev. Close
2,493
Open
2,493
Day's Range
2,443-2,499
52 wk Range
2,443-3,688
Volume
719.4K
Average Volume (3m)
966.27K
1-Year Change
-17.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4527 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3,510.0
Upside
+43.12%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years
Show more

Rohto Pharmaceutical Company Profile

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Employees
7259
Market
Japan

Compare 4527 to Peers and Sector

Metrics to compare
4527
Peers
Sector
Relationship
P/E Ratio
20.6x25.0x11.5x
PEG Ratio
−2.470.110.03
Price/Book
2.2x1.6x1.5x
Price / LTM Sales
2.0x1.2x0.9x
Upside (Analyst Target)
36.4%7.8%23.4%
Fair Value Upside
Unlock20.5%10.1%Unlock

Analyst Ratings

8 Buy
0 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3,510.0
(+43.12% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 119.5
Dividend Yield
1.32%
Industry Median 2.28%
Annualized payout
33
Paid unevenly
5-Years Growth
+19.92%
Growth Streak

Earnings

Latest Release
Nov 13, 2024
EPS / Forecast
19.46 / 35.07
Revenue / Forecast
70.73B / 71.02B
EPS Revisions
Last 90 days

People Also Watch

1,440.5
7267
+0.03%
45,870.0
6146
+2.48%
1,775.5
6752
-0.03%
1,697.00
285A
-1.16%

FAQ

What Is the Rohto Pharmaceutical (4527) Stock Price Today?

The Rohto Pharmaceutical stock price today is 2,452.50

What Stock Exchange Does Rohto Pharmaceutical Trade On?

Rohto Pharmaceutical is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Rohto Pharmaceutical?

The stock symbol for Rohto Pharmaceutical is "4527."

Does Rohto Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Rohto Pharmaceutical dividend yield is 1.32%.

What Is the Rohto Pharmaceutical Market Cap?

As of today, Rohto Pharmaceutical market cap is 559.74B.

What is Rohto Pharmaceutical Earnings Per Share?

The Rohto Pharmaceutical EPS is 119.50.

What Is the Next Rohto Pharmaceutical Earnings Date?

Rohto Pharmaceutical will release its next earnings report on Feb 11, 2025.

From a Technical Analysis Perspective, Is 4527 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.